Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Possible correlations between infertility and adverse metabolic profile: a case-control study. | Eur J Obstet Gynecol Reprod Biol | 2026 | 42308870 | PubTator, text mining | PubMed |
| Hepatogenomics of MAFLD in Asian Population: Genetic Polymorphisms and Pathway-Based Insights. | Diabetes Metab Syndr Obes | 2026 | 42299366 | PubTator, text mining | PubMed |
| Steatotic liver disease in Latin America: current views and perspectives. | Nat Rev Gastroenterol Hepatol | 2026 | 42298140 | PubTator, text mining | PubMed |
| Replication of acne susceptibility loci and gene-environment interactions with screen time in Singapore and Malaysia Chinese population. | JID Innov | 2026 | 42291617 | PubTator, text mining | PubMed |
| Egyptian MASLD genetic map; between the leading TM6SF2 gene and role of epigenetic. | J Appl Genet | 2026 | 42287598 | PubTator, text mining | PubMed |
Association of Genetic Variants in PNPLA3, MBOAT7, and MARC1 with Metabolic and Hematological Immune-Inflammation Indices in Adolescent Females with and Without MASLD: A Multilevel Risk-Allele Burden Analysis. | Int J Mol Sci | 2026 | 42278367 | PubTator, text mining | PubMed |
| Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers. | Hepatol Int | 2026 | 42274972 | PubTator, text mining | PubMed |
| LiRNA: An interactive atlas of human liver RNAseq databases. | JHEP Rep | 2026 | 42264302 | PubTator, text mining | PubMed |
| Global research trends of lean metabolic dysfunction-associated steatotic liver disease (lean MASLD) from 2005 to 2024: Bibliometric and visualization analysis. | Medicine (Baltimore) | 2026 | 42260851 | PubTator, text mining | PubMed |
| PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: A meta-analysis of observational studies. | JHEP Rep | 2026 | 42250763 | PubTator, text mining | PubMed |
| Uncovering Genetic Drivers of MASLD in South Asia: A Whole-Exome Sequencing Study in Pakistan. | J Coll Physicians Surg Pak | 2026 | 42219829 | PubTator, text mining | PubMed |
| Risk Factors for Hepatocellular Carcinoma in Latino Populations in Texas: A Scoping Review. | Int J Mol Sci | 2026 | 42196623 | PubTator, text mining | PubMed |
| Membrane bridges and nanodomain partitioning govern membrane protein targeting to lipid droplets. | Nat Cell Biol | 2026 | 42191894 | PubTator, text mining | PubMed |
| Meat Intake, Genetic Predispositions, and the Risk of Steatotic Liver Disease in a Cohort Study. | J Nutr | 2026 | 42162797 | PubTator, text mining | PubMed |
| Paediatric metabolic dysfunction-associated steatotic liver disease (MASLD): a growing health concern in the age of childhood obesity. | BMJ Paediatr Open | 2026 | 42161382 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America. | Clin Liver Dis | 2026 | 42142908 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management. | Clin Liver Dis | 2026 | 42142906 | PubTator, text mining | PubMed |
| Consistent efficacy of efruxifermin across PNPLA3 genotypes in phase 2b trials in MASH. | Hepatology | 2026 | 42127430 | PubTator, text mining | PubMed |
| UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis. | Int J Mol Sci | 2026 | 42123504 | PubTator, text mining | PubMed |
Polygenic Risk Score Predicts Prognosis in Nonobese Metabolic Dysfunction-Associated Steatotic Liver Disease but not in Obese Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: A Multicenter Cohort Study. | Clin Gastroenterol Hepatol | 2026 | 42107857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=3